rixubis
takeda new zealand limited - nonacog gamma 100 iu/ml equivalent to 500 iu/vial; - powder for injection - 100 iu/ml - active: nonacog gamma 100 iu/ml equivalent to 500 iu/vial excipient: calcium chloride dihydrate histidine mannitol polysorbate 80 sodium chloride sucrose water for injection - · routine prophylaxis of bleeding episodes in patients with haemophilia b · treatment & prevention of bleeding episodes in patients with haemophilia b (congenital factor ix deficiency) · peri-operative management in patients with haemophilia b
rixubis
takeda new zealand limited - nonacog gamma 200 iu/ml equivalent to 1000 iu/vial; - powder for injection - 200 iu/ml - active: nonacog gamma 200 iu/ml equivalent to 1000 iu/vial excipient: calcium chloride dihydrate histidine mannitol polysorbate 80 sodium chloride sucrose water for injection - · routine prophylaxis of bleeding episodes in patients with haemophilia b · treatment & prevention of bleeding episodes in patients with haemophilia b (congenital factor ix deficiency) · peri-operative management in patients with haemophilia b
rixubis
takeda new zealand limited - nonacog gamma 400 iu/ml equivalent to 2000 iu/vial; - powder for injection - 400 iu/ml - active: nonacog gamma 400 iu/ml equivalent to 2000 iu/vial excipient: calcium chloride dihydrate histidine mannitol polysorbate 80 sodium chloride sucrose water for injection - · routine prophylaxis of bleeding episodes in patients with haemophilia b · treatment & prevention of bleeding episodes in patients with haemophilia b (congenital factor ix deficiency) · peri-operative management in patients with haemophilia b
rixubis
takeda new zealand limited - nonacog gamma 50 iu/ml equivalent to 250 iu/vial; - powder for injection - 50 iu/ml - active: nonacog gamma 50 iu/ml equivalent to 250 iu/vial excipient: calcium chloride dihydrate histidine mannitol polysorbate 80 sodium chloride sucrose water for injection - · routine prophylaxis of bleeding episodes in patients with haemophilia b · treatment & prevention of bleeding episodes in patients with haemophilia b (congenital factor ix deficiency) · peri-operative management in patients with haemophilia b
rixubis
takeda new zealand limited - nonacog gamma 600 iu/ml equivalent to 3000 iu/vial; - powder for injection - 600 iu/ml - active: nonacog gamma 600 iu/ml equivalent to 3000 iu/vial excipient: calcium chloride dihydrate histidine mannitol polysorbate 80 sodium chloride sucrose water for injection - · routine prophylaxis of bleeding episodes in patients with haemophilia b · treatment & prevention of bleeding episodes in patients with haemophilia b (congenital factor ix deficiency) · peri-operative management in patients with haemophilia b
buster
basf new zealand limited - glufosinate-ammonium - glufosinate-ammonium 200 g/litre - herbicide
tyllanex herbicide
adama new zealand limited - terbuthylazine - terbuthylazine 500 g/litre - herbicide
arrow 360
adama new zealand limited - clethodim - clethodim 360 g/litre - herbicide
magneto
adama new zealand limited - terbuthylazine - terbuthylazine 500 g/litre - herbicide
dk-terb 900wg
danken new zealand limited - terbuthylazine - terbuthylazine 900 g/kg - herbicide